Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
VBCN - April 2014 Volume 1, No 1
AAN Updated Its Guidelines for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
By
Caroline Helwick
Stroke
VBCN - April 2014 Volume 1, No 1
Because atrial fibrillation is a major risk factor for ischemic stroke, there is a need for strategies to identify people at risk for stroke and prevent it at all ages. The American Academy of Neurology (AAN) has helped fill this gap with the release of new evidence-based guidelines.
Read More
Economic Analyses of Acute Ischemic Stroke Imaging Modalities Missing Important Data
By
Alice Goodman
Health Economics
VBCN - April 2014 Volume 1, No 1
Patients with stroke often require extensive inpatient and outpatient care that is associated with high expenditures and very high morbidity and mortality rates. Neuroimaging is an important component of care in patients with acute ischemic stroke, especially for guiding the use of thrombolysis. Imaging is associated with high costs and is being used more often today.
Read More
Elevated Fatty Acid Levels Increase Risk for Recurrent Stroke in Patients with Cardioembolic Stroke
In the Literature
VBCN - April 2014 Volume 1, No 1
Plasma free fatty acids (FFAs) are related to lipid metabolism, and elevated levels of FFA have been associated with risk factors for atherosclerosis, such as abdominal obesity, arterial hypertension, and insulin resistance.
Read More
For Patients with Multiple Sclerosis, Increasing Physical Activities May Be the Best Medicine
By
Rosemary Frei, MSc
Multiple Sclerosis
VBCN - April 2014 Volume 1, No 1
Lifestyle physical activity should be as central to the health-promoting habits of patients with multiple sclerosis (MS) as exercise training, according to one expert.
Read More
Glatiramer Acetate Injection Cost-Effective for Relapse Prevention in Patients with Multiple Sclerosis
By
Rosemary Frei, MSc
Health Economics
VBCN - April 2014 Volume 1, No 1
A recent Spanish economic analysis indicates that glatiramer acetate injection (Copaxone) is cost-effective for the prevention of relapses in patients with established relapsing-remitting multiple sclerosis (RRMS), according to recently published results.
Read More
Great Expectations: Disclosing Migraine Treatment Type to Patients Affects Clinical Outcomes
By
Lilly Ostrovsky, MS
Migraine
,
Migraine
VBCN - April 2014 Volume 1, No 1
Blinding of patients to their assigned treatment (active or placebo) is a standard procedure in clinical trials to assess the “true” efficacy of the active drug. But what happens when patients are certain whether they are receiving active treatment or placebo?
Read More
Growing Understanding of Genetic Causes of Progressive Myoclonic Epilepsies Improves the Diagnostic Workup
By
Caroline Helwick
Personalized Medicine in Neurology
VBCN - April 2014 Volume 1, No 1
The varied genetic causes of progressive myoclonic epilepsies (PMEs) are becoming better understood through genetic analyses. A team of Italian researchers recently contributed to the understanding of these rare diseases by defining the clinical spectrum and etiology of PMEs, using a database developed by the Genetics Commission of the Italian League against Epilepsy.
Read More
Men with NMDA Ar-Abs Encephalitis Have Different Presentation than Women
By
Alice Goodman
Parkinson’s Disease
VBCN - April 2014 Volume 1, No 1
Men with N-methyl-D-aspartate (NMDA) receptor antibodies (NMDAr-Abs) encephalitis present different from women, according to a recent study. Adult men are more likely to present with seizures, whereas women rarely present with seizures and are much more likely to present with behavioral and psychiatric features as their first symptom. Males and females have a similar course of global progression and similar recovery.
Read More
Migraine Prevalence Rises with Decline in Income, but Remission Is Stable
By
Charles Bankhead
Health Economics
VBCN - April 2014 Volume 1, No 1
Migraine prevalence increased significantly as household income declined in a retrospective analysis of a large migraine database, supporting a social-causation hypothesis in the etiology of migraine, investigators reported recently.
Read More
Neurologists Propose New Algorithm for First-Line Natalizumab in Selected Patients with Multiple Sclerosis
By
Rosemary Frei, MSc
Multiple Sclerosis
VBCN - April 2014 Volume 1, No 1
A team of neurologists have proposed a new algorithm to help clinicians determine which patients with relapsing forms of multiple sclerosis (MS) may be suitable for first-line treatment with natalizumab.
Read More
Page 1 of 3
1
2
3
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.